Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 79.78

0.0%

Dec 31 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (1810)	6/19/2007 1:02:04 PM
From: Jibacoa	Read Replies (2) of 3722

ALTH started to the upside today in spite of the failure of the PIII of EFAPROXYN to meet its primary endpoint of improvement on survival of patients with brain metastases from brain Ca. But by 9:50 AM the stock started to turn down after reaching its intraday H of 5.75. It seems to be finding support at the 5.40 to 5.45 level & the volume of 9,800,000 is already 39x its daily average.<g> bigcharts.marketwatch.com ALTH has no significant LTD & plans to discontinue further trials of EFAPROXYN and to focus on the development of PDX, which is on a PII in patients with relapsed or refractory PTCL. Will see if the stock will be able to hold above the $5 level, or it will come down to test the $3.65 to $4.25 level.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next